This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Dec;39(12):1783-5.

doi: 10.1111/j.1365-2222.2009.03396.x.

Adjuvants for immunotherapy: lost in translation?

D van Hemelen, A J M van Oosterhout

PMID: 20085594
DOI: 10.1111/j.1365-2222.2009.03396.x

Editorial

Adjuvants for immunotherapy: lost in translation?

D van Hemelen et al. Clin Exp Allergy. 2009 Dec.

. 2009 Dec;39(12):1783-5.

doi: 10.1111/j.1365-2222.2009.03396.x.

Authors

D van Hemelen, A J M van Oosterhout

PMID: 20085594
DOI: 10.1111/j.1365-2222.2009.03396.x

No abstract available

PubMed Disclaimer

Comment on

The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.
Majak P, Rychlik B, Stelmach I. Majak P, et al. Clin Exp Allergy. 2009 Dec;39(12):1830-41. doi: 10.1111/j.1365-2222.2009.03357.x. Epub 2009 Oct 7. Clin Exp Allergy. 2009. PMID: 19817753 Clinical Trial.

Similar articles

The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.
Majak P, Rychlik B, Stelmach I. Majak P, et al. Clin Exp Allergy. 2009 Dec;39(12):1830-41. doi: 10.1111/j.1365-2222.2009.03357.x. Epub 2009 Oct 7. Clin Exp Allergy. 2009. PMID: 19817753 Clinical Trial.
Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.
Boquete-París M. Boquete-París M. Allergol Immunopathol (Madr). 2013 Jan-Feb;41(1):1-3. doi: 10.1016/j.aller.2012.12.001. Epub 2013 Jan 10. Allergol Immunopathol (Madr). 2013. PMID: 23313160 No abstract available.
Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma.
Majak P, Rychlik B, Pułaski L, Błauz A, Agnieszka B, Bobrowska-Korzeniowska M, Kuna P, Stelmach I. Majak P, et al. J Allergy Clin Immunol. 2010 Jun;125(6):1220-7. doi: 10.1016/j.jaci.2010.02.034. J Allergy Clin Immunol. 2010. PMID: 20434204 Clinical Trial.
Regulatory T cells and asthma.
Robinson DS. Robinson DS. Clin Exp Allergy. 2009 Sep;39(9):1314-23. doi: 10.1111/j.1365-2222.2009.03301.x. Epub 2009 Jun 17. Clin Exp Allergy. 2009. PMID: 19538496 Review.
Mechanisms of sublingual immunotherapy.
Scadding G, Durham S. Scadding G, et al. J Asthma. 2009 May;46(4):322-34. doi: 10.1080/02770900902785729. J Asthma. 2009. PMID: 19484663 Review.

See all similar articles

Cited by

CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution.
De Maria A, Cossarizza A. De Maria A, et al. J Transl Med. 2011 Jun 16;9:93. doi: 10.1186/1479-5876-9-93. J Transl Med. 2011. PMID: 21679413 Free PMC article. Review.
Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental Allergy.
Chu HW, Lloyd CM, Karmaus W, Maestrelli P, Mason P, Salcedo G, Thaikoottathil J, Wardlaw AJ. Chu HW, et al. Clin Exp Allergy. 2010 Nov;40(11):1611-31. doi: 10.1111/j.1365-2222.2010.03625.x. Clin Exp Allergy. 2010. PMID: 21039970 Free PMC article. Review.
Adjuvants for allergy immunotherapeutics.
Gamazo C, D'Amelio C, Gastaminza G, Ferrer M, Irache JM. Gamazo C, et al. Hum Vaccin Immunother. 2017 Oct 3;13(10):2416-2427. doi: 10.1080/21645515.2017.1348447. Hum Vaccin Immunother. 2017. PMID: 28825867 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley